1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-46.68%
Negative revenue growth while RUN stands at 12.90%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-76.32%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-143.56%
Negative EBIT growth while RUN is at 23.91%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-132.73%
Negative operating income growth while RUN is at 0.47%. Joel Greenblatt would press for urgent turnaround measures.
-133.34%
Negative net income growth while RUN stands at 460.66%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-166.67%
Negative EPS growth while RUN is at 456.14%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-166.67%
Negative diluted EPS growth while RUN is at 436.85%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
4.01%
Share count expansion well above RUN's 1.22%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
-0.83%
Reduced diluted shares while RUN is at 1.26%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-216.20%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-51.35%
Negative FCF growth while RUN is at 156.78%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-19.45%
Negative 10Y revenue/share CAGR while RUN stands at 231.43%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-19.45%
Negative 5Y CAGR while RUN stands at 64.82%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
271.89%
Positive 3Y CAGR while RUN is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
87.52%
Positive long-term OCF/share growth while RUN is negative. John Neff would see a structural advantage in sustained cash generation.
87.52%
Positive OCF/share growth while RUN is negative. John Neff might see a comparative advantage in operational cash viability.
-484.83%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
94.31%
Below 50% of RUN's 1473.60%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
94.31%
Below 50% of RUN's 1185.12%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-2919.88%
Negative 3Y CAGR while RUN is 220.80%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
214.53%
Positive short-term equity growth while RUN is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-48.16%
Firm’s AR is declining while RUN shows 8.37%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
36.51%
Inventory growth well above RUN's 18.52%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
1.54%
Asset growth well under 50% of RUN's 4.18%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
5.44%
Under 50% of RUN's 11.80%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-2.21%
We’re deleveraging while RUN stands at 3.38%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
594.66%
We increase R&D while RUN cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-4.82%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.